SCHEMBL4573196

SCHEMBL4573196

CC(=O)NS(=O)(=O)CCc1ccc(N)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.53
TSHR P16473 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
RECQL P46063 1/20 0.51
MMP8 P22894 4/20 0.44
MMP12 P39900 4/20 0.44
MMP13 P45452 4/20 0.44
GFER P55789 1/20 0.42
MMP1 P03956 1/20 0.42
MMP7 P09237 1/20 0.42
PKM P14618 1/20 0.41
CYP2C19 P33261 1/20 0.41
ESRRG P62508 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
CA6 P23280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15625523 0.83 MMP8 (0.55) MMP8MMP12MMP13GFERMMP1
SCHEMBL11252664 0.81 MMP8 (0.54) MMP8MMP12MMP13GFERMMP1
SCHEMBL6454165 0.81 CXCR1 (0.49) TSHRSMN1; SMN2MMP8MMP12MMP13
SCHEMBL1275321 0.79 RECQL (0.58) TSHRTDP1RECQLMMP8MMP12
Hydrochloric Acid SCHEMBL4731092 0.77 RECQL (0.61) TSHRTDP1RECQLMMP8MMP12
SCHEMBL3082582 0.75 RECQL (0.53) RECQLMMP8MMP12MMP13GFER
SCHEMBL3532037 0.75 RECQL (0.53) RECQLMMP8MMP12MMP13GFER
SCHEMBL2044233 0.74 RECQL (0.67) TSHRTDP1RECQLGFERALDH1A1
SCHEMBL3532040 0.73 CA2 (0.56) SMN1; SMN2RECQLMMP8MMP12MMP13
SCHEMBL8899345 0.72 RECQL (0.64) TSHRTDP1RECQLGFERALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-15 US disclosed
WO-2008055013-A2 5-OXO-5,8 - DIHYDRO - PYRIDO - PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE FLT3, FES, ALK DHFR 71/4885TSHR 1688/4885SMN1; SMN2 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.